TestEinstein
Member
- Awards
- 0
I know about all the rate/order and half-life calculations, but I have a question about the starting point...
When a compound has a half-life of, for example, 6 hours, does that mean that t1/2=6 hours after plasma concentration peak, or initial oral administration. I ask because there is a significant lag time with oral AAS, partially modulated by simultaneous lipid consumption, so if I take 20mg of Epi (40%BA so roughtly 8mg bioavailable) with a ~6 hour half life at 12pm as part of a meal, I want to know if it hits the t1/2 (roughly 4mg bioavailable) at 6pm or closer to 8pm.
Also, do 17aas and non-methylated drugs have a similar latency before peak plasma concentration? That is, does Epi/SD/HD peak in the blood stream more quickly/slowly than M-LMG or 4-AD, given a similar dosage weight? I ask because plasma metabolite ratios would conceivably be affected by delays.
Thanks in advance guys.
When a compound has a half-life of, for example, 6 hours, does that mean that t1/2=6 hours after plasma concentration peak, or initial oral administration. I ask because there is a significant lag time with oral AAS, partially modulated by simultaneous lipid consumption, so if I take 20mg of Epi (40%BA so roughtly 8mg bioavailable) with a ~6 hour half life at 12pm as part of a meal, I want to know if it hits the t1/2 (roughly 4mg bioavailable) at 6pm or closer to 8pm.
Also, do 17aas and non-methylated drugs have a similar latency before peak plasma concentration? That is, does Epi/SD/HD peak in the blood stream more quickly/slowly than M-LMG or 4-AD, given a similar dosage weight? I ask because plasma metabolite ratios would conceivably be affected by delays.
Thanks in advance guys.